Whether your chip is running a vintage computer game or the latest DeepSeek model, it’ll reward you for speaking its native ...

EQT Life Sciences is pleased to announce that its LSP 7 fund has invested in Electra Therapeutics, a late-stage US biotechnology company developing innovative treatments for immune-mediated diseases ...

Sanofi’s Tzield accepted for expedited review in the US for stage 3 type 1 diabetes through FDA Commissioner's National Priority Voucher pilot program ...

Since launching its crackdown in Washington, D.C., the Trump administration has recorded over 3,500 arrests in the district, ...

Discover the latest press releases from Ralph C. Wilson, Jr. Foundation with the Buffalo Business First's BizSpotlight ...

Optic neuropathies including glaucoma, traumatic injury, ischemic damage, and optic neuritis, are the leading causes of irreversible blindness ...

Tzield, a monoclonal antibody approved for stage 2 Type 1 diabetes, now seeks approval for stage 3 disease based on trial ...

The nearly month long government shutdown will halt food SNAP benefits to tens of thousands of people in the New Orleans area beginning Nov. 1, including nearly one quarter of ...

Microsoft’s cross-platform .NET takes interesting dependencies, including a fork of Google’s Skia, now to be co-maintained ...